MS has long been considered a disease of focal white matter lesions, but recent studies have highlighted the importance of diffuse occult brain damage. Are we facing a paradigm shift? In this episode we'll talk to Dr. Jens Wuerfel about deep grey matter atrophy and advanced imaging to reveal and quantify occult damage of the CNS.

GZNO.MS.19.11.0310
MAT-GLB-2003394-v1.0

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

In Sanofi's podcast “The MS Podcast”, the focus is on Multiple Sclerosis and brain health. Through the different episodes we talk to various specialists within neuroscience, psychology  and physical activity to help shed light on the many aspects of treating MS. Tune in and learn more!